Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study-Reference-Cited by-同舟云学术

Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study

Published:2015-09-07 Issue:12 Volume:9 Page:1096-1107
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Launay Odile,Abitbol Vered,Krivine Anne,Slama Lilia Ben,Bourreille Arnaud,Dupas Jean Louis,Hébuterne Xavier,Savoye Guillaume,Deplanque Dominique,Bouhnik Yoram,Pelletier Anne Laure,Galtier Florence,Laharie David,Nachury Maria,Zerbib Frank,Allez Mathieu,Bommelaer Gilles,Duclos Bernard,Lucht Frederic,Gougeon Marie-Lise,Tartour Eric,Rozenberg Flore,Hanslik Thomas,Beaugerie Laurent,Carrat Fabrice,

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/9/12/1096/13746673/jjv152.pdf

Reference33 articles.

1. Inflammatory bowel disease: cause and immunobiology

2. Inflammatory bowel disease: clinical aspects and established and evolving therapies

3. Serious infections during anti-TNFα treatment in rheumatoid arthritis patients

4. Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

5. Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent clinical evidence on nutrition, novel pharmacotherapy, and vaccination in inflammatory bowel diseases;Frontiers in Pharmacology;2024-09-06

2. Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea;Intestinal Research;2024-07-31

3. Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study;BMJ Open Gastroenterology;2024-06

4. Higher and Sustained Cell-Mediated Immune Responses after Three Doses of mRNA COVID-19 Vaccine In Patients with Inflammatory Bowel Disease on Anti-TNF Therapy;Clinical and Translational Gastroenterology;2024-02-13

5. Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib;Journal of Crohn's and Colitis;2023-11-06